Becton, Dickinson & Co. posted net income of $1.23 billion on sales of $7.16 billion during fiscal 2009, up 9.3 percent and 1.2 percent, respectively, compared with net income of $1.13 billion on $7.07 billion in revenues last year.
The Franklin Lakes, N.J.-based medical device leviathan said fourth-quarter sales reached $1.9 billion, up 4.7 percent compared with $1.81 billion during the same period last year, with Q4 net income rising 12.4 percent to $317.2 million, compared with $282.2 million during the 2008 fourth quarter.
The fourth-quarter growth was paced by the company’s BD Medical segment, which saw Q4 revenues jump 8 percent to $1 billion. The Swine Flu played a role as well, driving strong sales for BD’s pharma systems and medical-surgical equipment units. Sales for the medical segment were flat for the full year.
BD’s diagnostics business posted Q4 sales of $580 million, up 5 percent from the prior-year period, with full-year sales up 3 percent to $2.23 billion. Its biosciences division reported sales of $312 million for the quarter, down 5 percent due to slumping capital equipment sales in the U.S; annual sales for the division grew 1 percent to $1.2 billion.
The company said it expects full-year sales to grow about 6 percent during fiscal 2010, with diluted earnings per share increasing 1 percent to 3 percent.